X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Alzheimers Disease Can Be Diagnosed By A Single Brain Scan

Content Team by Content Team
21st June 2022
in Manufacturing, Middle East and South Asia, News
Alzheimers Disease Can Be Diagnosed By A Single Brain Scan

Doctors currently use a variety of tests to identify Alzheimer’s disease, including memory and cognitive tests that can take several weeks to set up and interpret. Only one of these is required in the new method, which is an MRI brain scan performed on typical 1.5 Tesla equipment present in most hospitals. The new method is based on an algorithm that was created for classifying cancer tumours. Researchers classified the brain into areas and assigned distinct attributes to each, teaching the algorithm to spot changes in these aspects that might effectively indicate the presence of Alzheimer’s disease.

Over 400 individuals with early and late-stage Alzheimer’s disease, healthy controls, and individuals with other neurological conditions had their brains scanned. They also used data from over 80 patients at Imperial College Healthcare NHS Trust who were having Alzheimer’s diagnostic tests.

The researchers discovered that an MRI-based machine learning system could effectively determine whether a patient had Alzheimer’s disease in 98% of the cases. In 79% of patients, it was also able to distinguish between early and late-stage Alzheimer’s disease with a high degree of accuracy.

Alzheimer’s disease is the most frequent cause of dementia in the United Kingdom, impacting over half a million people. Although the condition is most common in people over the age of 65, it can also affect people younger than that. Although there is no cure for Alzheimer’s disease, there are medications that can help ease the symptoms.

Patients will be able to seek advice and support, receive therapy to control their symptoms, and prepare for the future sooner thanks to the technique’s ability to analyse the disease in its earliest stages, when it can be difficult to diagnose. Currently, no other simple and generally available approaches can predict Alzheimer’s disease with this level of accuracy, said Professor Eric Aboagye of Imperial College London’s Department of Surgery and Cancer, who conducted the research.

Awaiting a diagnosis can be a nightmare for patients and their families. It would be really beneficial if one could reduce the amount of time patients have to wait, make diagnosis an easier procedure, and remove some of the ambiguity. This new method could also help doctors find early-stage patients in clinical trials of novel drugs or lifestyle changes, which is now difficult to do.

Previous Post

U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

Next Post

Third Rock Ventures $1 Billion Fund To Aid Biotech Startups

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
Third Rock Ventures $1 Billion Fund To Aid Biotech Startups

Third Rock Ventures $1 Billion Fund To Aid Biotech Startups

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In